| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2002-06-1770 |
| P8608 | Fatcat ID | release_gocivq6nbjcmteekj6snmi5yum |
| P698 | PubMed publication ID | 12506034 |
| P5875 | ResearchGate publication ID | 6090312 |
| P50 | author | Hideo Yagita | Q89299610 |
| P2093 | author name string | Toshio Suzuki | |
| Hiroki Sato | |||
| Ko Okumura | |||
| Kazuya Takahashi | |||
| Noriko Yamaguchi | |||
| Shinpei Nakazawa | |||
| Atsushi Nemoto | |||
| Nobuhiko Kayagaki | |||
| Kanji Sugita | |||
| Takeshi Inukai | |||
| Keiko Kagami | |||
| Kumiko Goi | |||
| Kanako Uno | |||
| Toshiko Koyama-Okazaki | |||
| P4510 | describes a project that uses | K-562 | Q6324626 |
| KOPM-28 | Q54900295 | ||
| KOPM-30 | Q54900296 | ||
| KOPM-53 | Q54900297 | ||
| KOPN-30bi | Q54900300 | ||
| KOPN-55bi | Q54900312 | ||
| KOPN-57bi | Q54900313 | ||
| KOPN-66bi | Q54900321 | ||
| KOPN-72bi | Q54900323 | ||
| NALM-1 | Q54907391 | ||
| YAMN-73 | Q54995218 | ||
| YAMN-91 | Q54995222 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| Philadelphia chromosome | Q1129111 | ||
| apoptotic process | Q14599311 | ||
| TNF | Q18032037 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 3658-3667 | |
| P577 | publication date | 2002-12-27 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells | |
| P478 | volume | 101 |
| Q44355315 | A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines |
| Q42317482 | A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration |
| Q33213461 | Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia |
| Q40245988 | Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen |
| Q47115348 | Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines. |
| Q37102026 | Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia |
| Q39337116 | BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia |
| Q39656321 | BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients |
| Q35828737 | Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease |
| Q40573463 | Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation |
| Q35143436 | Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor |
| Q45947203 | Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3. |
| Q39682472 | Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells. |
| Q38832808 | HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia |
| Q27677425 | Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding |
| Q36131043 | Initiation factor modifications in the preapoptotic phase |
| Q28082840 | Modulation of inflammation by autophagy: Consequences for human disease |
| Q36804432 | Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects |
| Q39323262 | Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors |
| Q37071112 | Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib |
| Q41846489 | Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Expression in Primary Acute Leukemic Cells by Chemotherapeutics |
| Q39673837 | Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor−related apoptosis-inducing ligand-mediated apoptosis |
| Q79302950 | Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity |
| Q37864686 | Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy |
| Q35946035 | STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. |
| Q55239517 | Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand. |
| Q55471801 | Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors. |
| Q46128404 | Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. |
| Q40066615 | Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B-cell precursor acute lymphoblastic leukaemia |
| Q36590964 | TRAIL, caspases and maturation of normal and leukemic myeloid precursors |
| Q26745531 | The Philadelphia chromosome in leukemogenesis |
| Q34798476 | The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. |
| Q53559624 | Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. |
| Q44529294 | Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells |
| Q38066406 | While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do. |
| Q40616397 | Xylocydine, a Novel Inhibitor of Cyclin-Dependent Kinases, Prevents the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptotic Cell Death of SK-HEP-1 Cells |
Search more.